Ensayos clínicos

Inclusion Criteria:

• Patient is 18 years of age or older.
• Patient has a diagnosis of migraine.
• Patient has been newly prescribed fremanezumab, non-fremanezumab CGRP-pathway targeting preventive migraine medications, or non-CGRP-pathway targeting preventive migraine medications.
• Patient has had a blood pressure and heart rate measurement recorded by a healthcare provider within 1 week prior to or on the day of informed consent.

Exclusion Criteria:

• Patient has been previously treated with CGRP-pathway targeting preventive migraine medications.
• Per prior authorization criteria, patients will not receive approval for treatment with CGRP-pathway preventative migraine medications without prior treatment with non-CGRP medications.

Eligibility last updated 12/10/21. Questions regarding updates should be directed to the study team contact.